Dermatology News

SEATTLE — People in East Africa with HIV-related Kaposi’s sarcoma often have advanced disease and a poor survival outlook — and the situation has not improved in the last 5 years, a study found.

There are key sex-specific differences in how psoriatic arthritis manifests in patients, with women reporting worse outcomes and treatment response compared with men, according to a review published in The Journal of Rheumatology.

SCOTTSDALE, Ariz. — SAPHO is complex, but knowing its potential manifestations can help clinicians identify and help patients, according to a speaker at the Basic and Clinical Immunology for the Busy Clinician meeting.

During a military deployment to Iraq, a 14-month-old male in a refugee camp presented to sick call (Figure 1) for evaluation of a minor upper respiratory tract infection

A 12-year-old girl presents to the guest columnist’s office with a red, painful right auricle. The onset was yesterday, and it is worse today.

The optimal duration of antibiotic therapy has been a matter of some debate, and increasingly, research is showing that shorter durations are just as effective as longer courses for many infections.

Risankizumab improves symptoms and is well tolerated through 52 weeks in patients with psoriatic arthritis who respond inadequately to biologic therapies or conventional synthetic disease-modifying antirheumatic drugs, according to data.

A previously healthy 8-year-old boy dropped a 5-pound dumbbell on his right foot. After the accident, there was immediate pain, followed by swelling and erythema.

In 2021, Humira, the blockbuster biologic that has for years been the highest grossing drug in the world, accomplished something that no drug had previously achieved when its global revenues topped $20 billion.

The FDA has approved Idacio as the eighth biosimilar to adalimumab, for all eligible indications of the reference product, clearing the way for its U.S. release in 2023 alongside a deluge of other Humira biosimilars.